Abstract
The AIDS drugs re-sale scandal is spreading. GlaxoSmithKline is currently engaged in legal action with a British wholesaler, Dowelhurst, which obtained drugs intended for west Africa and diverted them back to the UK for re-sale to various National Health Service hospitals. This action follows a fine of £50 000 imposed in January on AA Worldwide Trading for trading in medicines without a licence after a case was brought against the company by the UK Medicines and Healthcare Regulatory Products Agency (MHRA). In late April, reports emerged that AIDS drugs intended for the Ukraine may have been diverted from their intended destination by UKAID. This UK-based organisation has bought AIDS drugs for shipping to the area but the MHRA and Médecins sans Frontières have no knowledge of UKAID supplying medicines there.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
